Subscribe to our press releases
ChromoGenics receives additional order for nursing home
ChromoGenics receives a new order for ConverLight® Dynamic of approximately SEK 0.7 million for delivery in the autumn.
The order includes a delivery of dynamic glass to a nursing home, Wilhelmsrogården in Jönköping including ConverLight® Dynamic and control system with delivery in the autumn of 2022. With this upgrade, an improved protection against solar heat radiation, a high insulation value and improved noise reduction are obtained. For the elderly, it is also especially good that the difference between shadows and light is toned down. For the property owner, the measure means low operating costs and better comfort for the tenant.
“We are very pleased that Wilhelmsrogården show us confidence and choose to improve their property with ConverLight® glass and technology from ChromoGenics. Studies show that our technology contributes to an improved indoor environment and increased well-being. It is inspiring for everyone at ChromoGenics to be able to contribute to an improved environment and well-being for our seniors” says Fredrik Fränding, CEO of ChromoGenics.
ChromoGenics is a proptech company that produces dynamic glass for real estate. The company’s product ConverLight® Dynamic, controls indoor comfort with high daylight transmission, great view and solar heat blocking and thereby reduces cost of cooling. ConverLight® Dynamic is based on a patented solution where electrochromic coatings are laminated in plastic film and then laminated between glass. The plastic film is easy to transport, so long shipments of bulky glass can be avoided. ChromoGenics also offers static glass, ConverLight® Static, and the ConverLight® Energy facade glass solution. ChromoGenics’ stock was listed on Nasdaq First North Growth Market in 2017 and has supplied glass technology to several major real estate companies.
ChromoGenics originates from world-leading research at Ångströmlaboratoriet at Uppsala University. The company’s production facility in Uppsala has been partially financed with conditional loans from Energimyndigheten (Energy Authority) in Sweden. ChromoGenics’ share (CHRO) is listed on Nasdaq First North Growth Market with Erik Penser Bank as Certified Adviser: firstname.lastname@example.org